⌘K

Home/Filings/4/0001214659-18-005741

4//SEC Filing

Brister Mark 4

Accession 0001214659-18-005741

CIK 0001427570other

View on SEC.gov Company Profile

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 9:34 PM ET

Size

4.9 KB

Accession

0001214659-18-005741

Insider Transaction Report

Form 4

Period: 2018-08-23

OBALON THERAPEUTICS INCOBLN

VP of Research and Development

Transactions

Award
Common Stock
2018-08-23$1.82/sh+107,142$194,998→ 338,634 total

Footnotes (2)

[F1]The reporting person purchased these shares directly from the issuer in a private placement.
[F2]Includes Restricted Shares that are subject to vesting.

Documents

1 file

4
marketforms-42786.xmlPrimary
PRIMARY DOCUMENT

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001323223

Filing Metadata

Form type: 4
Filed: Aug 26, 8:00 PM ET
Accepted: Aug 27, 9:34 PM ET
Size: 4.9 KB

View on SEC.gov